Christine Bialonczyk

2.8k total citations · 1 hit paper
21 papers, 2.1k citations indexed

About

Christine Bialonczyk is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Christine Bialonczyk has authored 21 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Internal Medicine, 19 papers in Hematology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Christine Bialonczyk's work include Venous Thromboembolism Diagnosis and Management (19 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Christine Bialonczyk is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (19 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Christine Bialonczyk collaborates with scholars based in Austria and France. Christine Bialonczyk's co-authors include Mirko Hirschl, Paul A. Kyrle, Sabine Eichinger, Erich Minar, Ansgar Weltermann, Klaus Lechner, Barbara Schneider, Milena Stain, Verena Schönauer and Wolfgang Speiser and has published in prestigious journals such as New England Journal of Medicine, Blood and The American Journal of Medicine.

In The Last Decade

Christine Bialonczyk

21 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism

2000 568 citations Paul A. Kyrle, Erich Minar et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Christine Bialonczyk

Since Specialization

Citations

This map shows the geographic impact of Christine Bialonczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Bialonczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Bialonczyk more than expected).

Fields of papers citing papers by Christine Bialonczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Bialonczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Bialonczyk. The network helps show where Christine Bialonczyk may publish in the future.

Co-authorship network of co-authors of Christine Bialonczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Bialonczyk. A scholar is included among the top collaborators of Christine Bialonczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Bialonczyk. Christine Bialonczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of recurrent venous thromboembolism by measuring ProC Global 2007 ·Thrombosis and Haemostasis ·Gregor Hron, Mirko Hirschl, Christine Bialonczyk, Erich Minar, Marietta Kollars, Paul A. Kyrle, Sabine Eichinger	9
2	Family History for Venous Thromboembolism and the Risk for Recurrence 2006 ·The American Journal of Medicine ·Gregor Hron, Sabine Eichinger, Ansgar Weltermann, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Milena Stain, (unknown), Paul A. Kyrle	49
3	Interleukin-6 and interleukin-6 promoter polymorphism (−174) G>C in patients with spontaneous venous thromboembolism 2006 ·Thrombosis and Haemostasis ·Rainer Vormittag, Kety Hsieh, Alexandra Kaider, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Christine Mannhalter, Ingrid Pabinger	28
4	Interleukin-6 and interleukin-6 promoter polymorphism (-174) G > C in patients with spontaneous venous thromboembolism. 2006 ·PubMed ·Rainer Vormittag, Kety Hsieh, Alexandra Kaider, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Christine Mannhalter, Ingrid Pabinger	30
5	C-reactive protein 3′ UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism 2005 ·Atherosclerosis ·Rainer Vormittag, Marion Funk, Christine Mannhalter, Verena Schönauer, Thomas Vukovich, E Minar, Christine Bialonczyk, Mirko Hirschl, Ingrid Pabinger	14
6	Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism 2005 ·Thrombosis and Haemostasis ·Rainer Vormittag, Thomas Vukovich, Verena Schönauer, Stephan Lehr, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Ingrid Pabinger	29
7	The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease 2005 ·Journal of Thrombosis and Haemostasis ·(unknown), Verena Schönauer, E Minar, Christine Bialonczyk, Mirko Hirschl, A. Weltermann, Paul A. Kyrle, Sabine Eichinger	217
8	Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism. 2005 ·PubMed ·Rainer Vormittag, Thomas Vukovich, Christine Mannhalter, Erich Minar, Verena Schönauer, Christine Bialonczyk, Mirko Hirschl, Ingrid Pabinger	18
9	The risk of recurrent venous thromboembolism in men and women 2004 ·Journal of Vascular Surgery ·Paul A. Kyrle, E Minar, Christine Bialonczyk	1
10	The Risk of Recurrent Venous Thromboembolism in Men and Women 2004 ·New England Journal of Medicine ·Paul A. Kyrle, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Ansgar Weltermann, Sabine Eichinger	356
11	The risk of recurrent venous thromboembolism among patients with high factor IX levels 2003 ·Journal of Thrombosis and Haemostasis ·A. Weltermann, Sabine Eichinger, Christine Bialonczyk, E Minar, Mirko Hirschl, Peter Quehenberger, Verena Schönauer, Paul A. Kyrle	70
12	Superficial thrombophlebitis and risk for recurrent venous thromboembolism 2003 ·Journal of Vascular Surgery ·Verena Schönauer, Paul A. Kyrle, Ansgar Weltermann, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Peter Quehenberger, Barbara Schneider, H Partsch, Sabine Eichinger	36
13	Is the determination of anti‐beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? 2003 ·British Journal of Haematology ·Kety Hsieh, Paul Knöbl, C. Rintelen, Paul A. Kyrle, Peter Quehenberger, Christine Bialonczyk, H Partsch, Klaus Lechner, Ingrid Pabinger	10
14	The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor V Leiden and a First Spontaneous Venous Thromboembolism 2002 ·Archives of Internal Medicine ·Sabine Eichinger, Ansgar Weltermann, Christine Mannhalter, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Verena Schönauer, Klaus Lechner, Paul A. Kyrle	59
15	High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism breakdown → 2000 ·New England Journal of Medicine ·Paul A. Kyrle, Erich Minar, Mirko Hirschl, Christine Bialonczyk, Milena Stain, Barbara Schneider, Ansgar Weltermann, Wolfgang Speiser, Klaus Lechner, Sabine Eichinger	568
16	The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene 1999 ·Thrombosis and Haemostasis ·Erich Minar, Mirko Hirschl, Christine Bialonczyk, Milena Stain, Christine Mannhalter, (unknown), Barbara Schneider, Klaus Lechner, (unknown), Sabine Eichinger	106
17	Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. 1998 ·PubMed ·(unknown), A Stümpflen, Mirko Hirschl, Christine Bialonczyk, K. Herkner, (unknown), Barbara Schneider, Ingrid Pabinger, Klaus Lechner, Paul A. Kyrle	186
18	Levels of Prothrombin Fragment F1+2 in Patients with Hyperhomocysteinemia and a History of Venous Thromboembolism 1997 ·Thrombosis and Haemostasis ·Paul A. Kyrle, A Stümpflen, Mirko Hirschl, Christine Bialonczyk, K. Herkner, Wolfgang Speiser, Ansgar Weltermann, Alexandra Kaider, Ingrid Pabinger, Klaus Lechner, Sabine Eichinger	23
19	Prothrombin Fragment F1+2 Is not Predictive for Recurrent Venous Thromboembolism 1997 ·Thrombosis and Haemostasis ·Paul A. Kyrle, Sabine Eichinger, Ingrid Pabinger, A Stümpflen, Mirko Hirschl, Christine Bialonczyk, Barbara Schneider, Christine Mannhalter, (unknown), (unknown), A. Weltermann, Wolfgang Speiser, Klaus Lechner	23
20	The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden 1997 ·Thrombosis and Haemostasis ·Sabine Eichinger, Ingrid Pabinger, (unknown), Mirko Hirschl, Christine Bialonczyk, Barbara Schneider, Christine Mannhalter, Erich Minar, Klaus Lechner, Paul A. Kyrle	165

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact